Provided by Tiger Trade Technology Pte. Ltd.

Zura Bio

5.23
-0.0600-1.13%
Post-market: 5.230.00000.00%19:34 EDT
Volume:366.21K
Turnover:1.91M
Market Cap:496.23M
PE:-4.87
High:5.48
Open:5.30
Low:5.12
Close:5.29
52wk High:7.44
52wk Low:1.35
Shares:94.88M
Float Shares:50.84M
Volume Ratio:0.59
T/O Rate:0.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0748
EPS(LYR):-1.0600
ROE:-40.96%
ROA:-25.39%
PB:2.29
PE(LYR):-4.93

Loading ...

Zura Bio Initiated at Outperform by William Blair

Dow Jones
·
Jul 09

William Blair Initiates Zura Bio at Outperform

MT Newswires Live
·
Jul 08

Zura Bio initiated with an Outperform at William Blair

TIPRANKS
·
Jul 08

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Qiagen (QGEN) and Zura Bio (ZURA)

TIPRANKS
·
Jul 08

Zura Bio Releases Investor Presentation on Tibulizumab Dual IL-17 and BAFF Blockade in Immune Disorders

Reuters
·
Jul 02

Zura Bio Price Target Maintained with a $15.00/share by Wedbush

Dow Jones
·
Jul 01

We're Hopeful That Zura Bio (NASDAQ:ZURA) Will Use Its Cash Wisely

Simply Wall St.
·
Jun 30

Guggenheim Sticks to Its Buy Rating for Zura Bio (ZURA)

TIPRANKS
·
Jun 30

Tenaya Therapeutics Names Eric Hyllengren CFO

MT Newswires Live
·
Jun 29

Zura Bio Completes Phase 2 HS Trial Enrollment for Tibulizumab, Exceeding Target at 247 Participants

Reuters
·
Jun 29

Zura Bio VP, Principal Accounting Officer Mathew Marlyn Teresa files initial beneficial ownership statement

Reuters
·
Jun 23

Zura Bio Shareholders Back Board, Auditor and Equity Plan

TIPRANKS
·
Jun 19

Zura Bio shareholders approve amended 2023 equity incentive plan at annual meeting

Reuters
·
Jun 19

Zura Bio (ZURA) Gets a Buy from Oppenheimer

TIPRANKS
·
Jun 12

Zura Bio posts investor deck spotlighting tibulizumab dual IL-17 and BAFF approach for immune disorders

Reuters
·
Jun 03

Zura Bio Announces Board Resignation, Governance Stability Affirmed

TIPRANKS
·
May 23

Zura Bio director Someit Sidhu resigns from board effective May 21

Reuters
·
May 23

Zura Bio grants Chief Business Officer option for 600,000 shares at $4.8###

Reuters
·
May 14

Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 14

Zura Bio appoints Muzammil Mustufa chief business officer

Reuters
·
May 13